Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer.
about
Cancer immunoediting from immune surveillance to immune escapeThe role of CD95 and CD95 ligand in cancerCeramide mediates FasL-induced caspase 8 activation in colon carcinoma cells to enhance FasL-induced cytotoxicity by tumor-specific cytotoxic T lymphocytesIncreased serum soluble Fas after major trauma is associated with delayed neutrophil apoptosis and development of sepsisMiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3.Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.Death receptor pathways mediate targeted and non-targeted effects of ionizing radiations in breast cancer cells.Immunotherapy for liver tumors: present status and future prospects.Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer.Kisspeptin effect on endothelial monocyte activating polypeptide II (EMAP-II)-associated lymphocyte cell death and metastases in colorectal cancer patientsPrognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review.Early septic insult in neonatal pigs increases serum and urinary soluble Fas ligand and decreases kidney function without inducing significant renal apoptosis.Role of apoptosis resistance in immune evasion and metastasis of colorectal cancer.FasL gene knock-down therapy enhances the antiglioma immune response.Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.Cisplatin-induced oxidative stress stimulates renal Fas ligand shedding.
P2860
Q24655415-D20A4B40-25C4-4244-B7AB-C2E95F186213Q26995847-D477A074-2C0A-4B56-8153-27509730E442Q30357159-E01ED0F0-7988-47C9-AB9A-E87657456A1FQ35567208-8B787E1B-D85D-4349-AC4E-E40D806F634FQ35579040-64AAC906-943A-4115-96DB-E101A3F0EA28Q36695892-A2B4A691-275F-4143-BF18-FBD5779C8C0BQ37116325-746F6A1F-5A8A-4613-BC74-960ED8099D3CQ37144014-7CFE361F-04B5-42BA-9B05-B1C00330FF35Q37237661-B39D7686-E988-46C5-8C67-B9611B44AE72Q37649956-5007436A-D8CA-467B-A2C6-6A23536E4974Q37730438-4E1F719D-9262-4DF9-80E3-B1563F292F2EQ40494539-CF4CE4D8-1C9E-4B86-A530-D091EA3E3130Q41114891-2321B31F-4DCA-4E79-8B01-D8F3664B0A6AQ42425989-89D0B079-2A87-4D79-9FC7-46B96AFB8E63Q50026061-80F8729C-A4BD-40D8-932B-9701F3293000Q55385725-C93B8F21-B5D7-441E-AA36-4FA68B41FE2C
P2860
Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Soluble Fas ligand released by ...... mmune evasion in colon cancer.
@ast
Soluble Fas ligand released by ...... mmune evasion in colon cancer.
@en
type
label
Soluble Fas ligand released by ...... mmune evasion in colon cancer.
@ast
Soluble Fas ligand released by ...... mmune evasion in colon cancer.
@en
prefLabel
Soluble Fas ligand released by ...... mmune evasion in colon cancer.
@ast
Soluble Fas ligand released by ...... mmune evasion in colon cancer.
@en
P2093
P2860
P356
P1476
Soluble Fas ligand released by ...... mmune evasion in colon cancer.
@en
P2093
P2860
P304
P356
10.1038/SJ.BJC.6692042
P407
P577
2001-09-01T00:00:00Z